Skip to content

Clinical trials

Alzheimer Disease trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Puerto Rico Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20073
20093
20122
20141
20151
20161
20172
20181
20203
20216
20224
20245
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13
Completed12
Recruiting8
Active, not recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Washington University School of Medicine6
Eli Lilly and Company5
Axsome Therapeutics, Inc.3
Bristol-Myers Squibb3
Hoffmann-La Roche3
AstraZeneca2
Cassava Sciences, Inc.2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Otsuka Pharmaceutical Development & Commercialization, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease39
Dementia16
Psychomotor Agitation7
Cognitive Dysfunction5
Brain Diseases3
Central Nervous System Diseases2
Mental Disorders2
Nervous System Diseases2
Neurocognitive Disorders2
Plaque, Amyloid2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.